Delivery Order SPE2DB22D3501-SPE2DB25FWJ48
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,123.67 firm fixed-price contract is for the delivery of Remifentanil 5 mg vials, a specialized pain medication. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 1 mg vials, a prescription pain medication. The contract has a ceiling value of $4,925.60 and is a firm fixed price, non-set-aside contract with a performance period ending on June 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 1 mg vials of the pharmaceutical drug remifentanil, with a firm fixed price ceiling value of $3,072.30 and a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,489.05 contract is for the delivery of Remifentanil 5 mg vials, with a period of performance ending on June 30, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, a prescription medication. The contract has a firm fixed price, a ceiling value of $9,989.54, and an ultimate completion date of June 26, 2025. This delivery order is not set aside for any specific business type. Amerisourcebergen Drug Corp holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.19 Firm Fixed Price delivery order contract is for the supply of REMIFENTANIL 2 MG VIALS, a specialty medication. The contract has an ultimate completion date of April 3, 2025 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2 mg vials of the medication Remifentanil. The contract has a firm fixed price of $3,039.11 and a completion date of June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil. The $1,063.41 firm fixed price delivery order contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply this critical care medication to support...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on May 12, 2025. The contract has a ceiling value of $1,075.15 and is for the delivery of REMIFENTANIL 2 MG VIALS. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWJ48Delivery Order
This is a $3,897.31 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 2 mg vials, a medication used for pain management. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of that larger contract vehicle, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 7/10/25 |